Levodopa and Parkinson's Disease
Levodopa is a medication used to treat symptoms of Parkinson's Disease. Welders that have been exposed to the toxic elements of manganese have been shown to have an earlier onset of Parkinson's Disease. Parkinson's Disease is characterized by certain symptoms, including tremors, stiffness, and slow movement which Levodopa can help ease. Levodopa can also help control other Parkinson's Disease symptoms like excessive salivation problems and oily skin.
The dangers of exposure to manganese are especially prevalent in the welding industry. Reports show that welders developed Parkinson's Disease 15 years before the rest of the general population. Since the average duration of Parkinson's Disease to death is about 15 years, so the life expectancy for welders with manganese exposure can be drastically reduced. Levodopa is considered the most effective treatment available for Parkinson's Disease, and although there is no cure for Parkinson's Disease, Levodopa is able to reduce the symptoms.
The introduction of Levodopa Parkinson's Disease treatment was revolutionary in its effectiveness. Even before symptoms of Parkinson's Disease become apparent, degeneration of around 50-60% of dopamine neurons can occur, and by the time the Parkinson's Disease sufferer dies, a loss of over 90% of dopamine has often been suffered. The introduction of Levodopa can allow access to the brain in order to convert to dopamine and help improve Parkinson's Disease symptoms. Before Levodopa dopamine was unable to cross the blood-brain barrier to be used as a direct treatment for Parkinson's Disease.
Welders that have developed Parkinson's' Disease from exposure to the highly toxic element manganese may find Levodopa to be an effective treatment method. For more information on manganese induced Parkinson's Disease and Levodopa please contact a Levodopa Lawyer.
